HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NARB Tells Origins To Drop Comparison To Rx Anti-Wrinkle Products

This article was originally published in The Rose Sheet

Executive Summary

The National Advertising Review Board upholds a NAD ruling that the brand should discontinue claims comparing its Plantscription anti-aging serum to anti-wrinkle prescription products. NARB reversed several other NAD decisions on certain claims for the same product.

You may also be interested in...

Origins Appeals To NARB Following Case Over Plantscription Claims

The Estee Lauder Companies’ Origins unit is appealing to NARB after NAD advised the firm to drop or modify claims comparing its Plantscription products to anti-aging prescription cream Renova.

NAD Takes Issue With University Medical WrinkleFree Claims...Again

Performance claims from University Medical Pharmaceuticals touting the quick-acting effect of its WrinkleFree Eyes and comparing the product to Botox should be discontinued, the National Advertising Division says

Euromonitor: Value Shopping, Gender-Blurring Among Top Consumer Trends For 2106

A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts